Bharat Biotech

Hyderabad, India· Est. 1996

A pioneering Indian biotech company developing and manufacturing innovative, affordable vaccines for infectious diseases, with over 2 billion doses delivered globally.

bharatbiotech.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

A pioneering Indian biotech company developing and manufacturing innovative, affordable vaccines for infectious diseases, with over 2 billion doses delivered globally.

Infectious Disease

Technology Platform

Utilizes multiple vaccine platforms including whole-virion inactivated Vero cell technology, conjugate vaccine technology, and recombinant protein expression systems for developing novel vaccines against infectious diseases.

Opportunities

Significant growth opportunities in global vaccine markets, particularly for WHO-prequalified products in emerging economies, and potential for platform expansion to address pandemic threats and neglected tropical diseases.

Risk Factors

Intense competition from global vaccine manufacturers, regulatory challenges for new market entries, and dependence on government tenders and international procurement agencies for revenue.

Competitive Landscape

Competes with multinational vaccine companies like GSK, Merck, and Sanofi, as well as Indian competitors like Serum Institute, but differentiates through proprietary innovations like thermostable formulations and WHO-prequalified first-in-class vaccines for typhoid and rotavirus.

More companies in India →